24 January 2018
News and Views
Links and Services
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease, reports the latest issue of Gastroenterology.
Dr Paul Rutgeerts and colleagues from Belgium investigated the efficacy of adali
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors